Shahzad Malik Insider Trading $ITRM Iterum Therapeutics plc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Shahzad Malik.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Shahzad Malik. Shahzad Malik is Director in AGENUS INC ($AGEN) and Director in Conatus Pharmaceuticals Inc. ($CNAT) and Director in Versartis, Inc. ($VSAR) and Director in Acutus Medical, Inc. ($AFIB) and Director in Axonics Modulation Technologies, Inc. ($AXNX) and Director in Iterum Therapeutics plc ($ITRM).
Shahzad Malik in Iterum Therapeutics plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Shahzad Malik: Director
Holdings: 13,921 shares
Latest Transaction: Jun 17 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Shahzad Malik in Iterum Therapeutics plc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AFIB, AGEN, ARAV, AXNX, HSTO, ITRM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2019 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Option Exercise | A | 6.74 | 19,671 | 132,583 | 19,671 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 218,338 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 391,147 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 7,771 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 13,921 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Buy | P | 13.00 | 228,840 | 2,974,920 | 838,325 | 609.5 K to 838.3 K (+37.55 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Buy | C | 0.00 | 218,338 | 0 | 609,485 | 391.1 K to 609.5 K (+55.82 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Buy | C | 0.00 | 391,147 | 0 | 391,147 | 0 to 391.1 K |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Buy | P | 13.00 | 8,144 | 105,872 | 29,836 | 21.7 K to 29.8 K (+37.54 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Buy | C | 0.00 | 7,771 | 0 | 21,692 | 13.9 K to 21.7 K (+55.82 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Buy | C | 0.00 | 13,921 | 0 | 13,921 | 0 to 13.9 K |
| May 29 2018 | ITRM | Iterum Therapeutic ... | Malik Shahzad | Director | Option Exercise | A | 13.00 | 11,241 | 146,133 | 11,241 |
Page: 1